Zobrazeno 41 - 50
of 59
pro vyhledávání: '"33"'
Autor:
Hung-Chieh Yeh, Chiu-Ching Huang, Hsin-Hung Lin, Tzung-Hai Yen, Chih-Chia Liang, Jiung-Hsiun Liu, I-Kuan Wang, Chiz-Tzung Chang, Huey-Liang Kuo, Cheng-Chieh Hung
Publikováno v:
Lupus. 19(10)
Objective: Although there have been many studies on systemic lupus erythematosus (SLE) patients, there are few data about survival analysis of lupus patients receiving dialysis. Therefore, the objective of this study is to analyze risk factors predic
Publikováno v:
Lupus. 18(4)
We report the clinicopathological features, treatment and outcome of 54 Indian children (14 boys) with biopsy-proven lupus nephritis followed over a 10-year period. The mean age (SD) at onset of disease was 9.6 ± 2.6 (range 2.5–14.4) years. Twenty
Autor:
Guillermo Ruiz-Irastorza, Jose Gabriel Erdozain, Irama Villar, Ciriaco Aguirre, Maider Garmendia, Agustin Martinez-Berriotxoa, Maria-Victoria Egurbide
Publikováno v:
Lupus. 16(10)
Fluctuations in the titers of anticardiolipin antibodies (aCL) have been reported in systemic lupus erythematosus (SLE) patients, but their relation with thrombosis is not completely understood. Prospective inception cohort of 237 patients with SLE (
Publikováno v:
Lupus. 16(2)
Seventy-two patients with antiphospholipid antibodies (aPL), with or without antiphospholipid syndrome (APS), were studied for detection of heparin-PF4-induced antibodies (HPIA) using a commercial kit (Asserachrom® HPIA) PF4-dependant enzyme-linked
Autor:
A.J. Chamorro, Jordi Yagüe, J C Botero, Miguel Ingelmo, S Segura, Ricard Cervera, Manuel Ramos-Casals, Josep Font, G Salvador, M T Campoamor
Publikováno v:
Lupus. 13(10)
The objective of the study was to analyse the prevalence and clinical significance of hypocomplementemia in a large series of patients diagnosed either with systemic lupus erythematosus (SLE) or with primary antiphospholipid syndrome (APS) and its as
Publikováno v:
Lupus. 13(1)
The objective of this study was to determine the expression and activity of CTLA4 in T-cells of systemic lupus erythematosus (SLE) patients. Expression of CTLA4 on freshly isolated peripheral blood T-cells was evaluated in 33 SLE patients and 25 cont
Autor:
Elizabeth A. Wright, Alison J. Partridge, Rosalind Ramsey-Goldman, Paul R. Fortin, Matthew H. Liang, C. Rivest, Elizabeth W. Karlson, Lawren H. Daltroy
Publikováno v:
Lupus. 12(4)
The goal of this work was to develop an economical way of tracking disease activity for large groups of systemic lupus erythematosus (SLE) patients in clinical studies. A Systemic Lupus Activity Questionnaire (SLAQ) was developed to screen for possib
Autor:
A F Masri, Nora Pashayan, Thurayya Arayssi, S Shaar, Samir F. Atweh, Stella Major, Imad Uthman, R Chidiac-Tannoury
Publikováno v:
Lupus. 11(11)
The objective of the study was to describe the practice patterns of the antiphospholipid syndrome (APS) as compared with consensus guidelines for diagnosis and to determine whether practice patterns correlate with patient demographics and physician s
Autor:
Juan Carlos Reverter, Ricard Cervera, F. J. Muñoz-Rodriguez, Josep Font, Gerard Espinosa, Francisco Carmona, Juan Balasch, Dolors Tàssies, Antonio Ordinas, Miguel Ingelmo
Publikováno v:
Lupus. 11(11)
Antiphospholipid antibodies (aPL) may induce acquired activated protein C resistance (acquired APCR). The role of acquired APCR in patients with systemic lupus erythematosus (SLE) is not well known. To evaluate the prevalenceof acquiredAPCR and its a
Autor:
Stefano Bombardieri, Walter Bencivelli, Rossella Neri, R Puccini, S Giannessi, A. Pasquariello, Marta Mosca
Publikováno v:
Lupus. 10(4)
The incidence of renal flares and the long-term outcome in a group of 33 systemic lupus erythematosus (SLE) patients with diffuse proliferative glomerulonephritis (DPGN) treated with pulse steroids and a short course of pulse cyclophosphamide (CYC) a